We are live on ! Find out more
IMTX icon

Immatics

76 hedge funds and large institutions have $412M invested in Immatics in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more call options, than puts

Call options by funds: $1.66M | Put options by funds: $722K

14% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 21

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.77% less ownership

Funds ownership: 77.31%76.54% (-0.77%)

11% less funds holding

Funds holding: 8576 (-9)

37% less capital invested

Capital invested by funds: $656M → $412M (-$244M)

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

Holders
76
Holders Change
-9
Holders Change %
-10.59%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
15
Increased
24
Reduced
21
Closed
24
Calls
$1.66M
Puts
$722K
Net Calls
+$938K
Net Calls Change
+$1.86M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$66.2M +$21.2M +4,072,226 +38%
PA
2
Perceptive Advisors
New York
$42.3M
SCM
3
Suvretta Capital Management
New York
$41.2M +$21.2M +4,069,752 +80%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$38.7M -$9.57M -1,834,324 -18%
BBA
5
Baker Bros. Advisors
New York
$32.8M
VPC
6
Vestal Point Capital
New York
$32.4M +$4.79M +917,700 +15%
RI
7
RTW Investments
New York
$31.2M +$1.93M +368,970 +6%
Morgan Stanley
8
Morgan Stanley
New York
$14M +$3.42M +655,568 +27%
O
9
OrbiMed
New York
$13.9M
Toronto Dominion Bank
10
Toronto Dominion Bank
Ontario, Canada
$13.4M +$15.5M +2,973,032 New
Goldman Sachs
11
Goldman Sachs
New York
$8.96M -$2.05M -393,114 -17%
PBA
12
Paradigm Biocapital Advisors
New York
$8.6M -$18.3M -3,507,301 -65%
RCM
13
RA Capital Management
Massachusetts
$7.89M
WP
14
Woodline Partners
California
$7.6M -$1.83M -349,939 -17%
SI
15
Sofinnova Investments
California
$7.01M +$6.32M +1,211,098 +353%
FLSM
16
Frazier Life Sciences Management
California
$5.63M -$4.7M -900,000 -42%
SFM
17
Sphera Funds Management
Israel
$4.15M
BlackRock
18
BlackRock
New York
$3.42M +$376K +72,152 +11%
Aberdeen Group
19
Aberdeen Group
United Kingdom
$3.25M +$1.94M +372,207 +107%
UOTTAIMCU
20
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$3.15M
6CM
21
683 Capital Management
New York
$2.77M -$183K -35,000 -5%
WA
22
Wasatch Advisors
Utah
$2.61M -$1.98M -379,389 -40%
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$2.16M +$1.53M +293,125 +158%
Schroder Investment Management Group
24
Schroder Investment Management Group
United Kingdom
$1.98M
PIM
25
Platinum Investment Management
Australia
$1.41M

IMTX Hedge Fund Activity: Q1 2025 in Review

76 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Immatics (IMTX) for Q1 2025, worth a combined $412M — down 37% from $656M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of IMTX and 15 opened new positions — a net loss of 9 holders — while 21 trimmed existing stakes and 24 added.

The largest buyer was T. Rowe Price Investment Management, adding an estimated $21.2M. The largest seller was Braidwell, exiting entirely with an estimated $24.9M sold.

  • 76 institutional investors held Immatics (IMTX) as of Q1 2025, down from 85 in Q4 2024.
  • Funds reported $412M of Immatics stock for Q1 2025, down 37% quarter-over-quarter.
  • 15 funds opened new Immatics positions in Q1 2025 and 24 closed out, a net change of -9 holders.
  • The largest Immatics buyer in Q1 2025 was T. Rowe Price Investment Management, an estimated $21.2M added.
  • The largest Immatics seller in Q1 2025 was Braidwell, an estimated $24.9M sold.

Based on aggregated 13F filings for Q1 2025.